Condition: Myocarditis Acute · Sponsor: Niguarda Hospital
This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).
This description comes directly from the study's public registry record.
Enrico Ammirati, MD, PhD · +39 0264447791 · enrico.ammirati@ospedaleniguarda.it
Always discuss trial participation with your own doctor first.
| University of California San Diego | San Diego, California, United States | Recruiting |
| University of Texas | Houston, Texas, United States | Not Yet Recruiting |
| University of Virginia | Charlottesville, Virginia, United States | Recruiting |
| Virginia Commonwealth University | Richmond, Virginia, United States | Not Yet Recruiting |
| Medical University of Graz | Graz, Austria | Recruiting |
| Medical University Innsbruck | Innsbruck, Austria | Not Yet Recruiting |
| Medical University of Wien | Vienna, Austria | Recruiting |
| Onze Lieve Vrouwziekenhuis | Aalst, Belgium | Recruiting |
| Antwerp University Hospital | Edegem, Belgium | Recruiting |
| Jessa Hospital Hasselt | Hasselt, Belgium | Recruiting |
| University Hospitals Leuven | Leuven, Belgium | Recruiting |
| Masaryk University and St. Anne's University Hospital | Brno, Czechia | Recruiting |
+ 37 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05150704